We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HER:MILHera S.p.A. Analysis

Data as of 2026-06-17 - not real-time

€3.78

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Hera shares are trading at €3.78, comfortably above the computed support of €3.724 but still below the 20‑day SMA of €3.816, indicating a short‑term price cushion yet a bearish alignment with SMA‑20, SMA‑50 and SMA‑200. The RSI sits at 42.6, suggesting neutral momentum, while the MACD histogram turned positive (+0.007) and the signal line is bullish, hinting at a possible bottom‑side reversal. Volume is increasing, which often precedes a move once technical pressure eases.
Fundamentally, the stock appears undervalued – a trailing P/E of 11.8 versus the industry average of 20.7 and a P/B of 1.31 – but revenue has contracted by 18% and the company carries a high debt‑to‑equity ratio of 120.5, raising concerns about financial resilience. Margins are thin (gross 19%, operating 7%) and free cash flow is modest at €64.9 m, though operating cash flow remains healthy at €1.33 bn. The low beta (≈0.22) and a 30‑day volatility of 16.6% point to relatively stable price swings, while the “Extreme Greed” sentiment index (92.8) reflects strong market appetite despite the bearish trend direction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price sitting just above technical support
  • bearish SMA alignment despite bullish MACD signal
  • increasing volume indicating potential breakout

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • undervalued relative to industry peers
  • high debt load limiting upside
  • stable operating cash flow in a regulated utility sector

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • low beta and modest volatility suggest defensive profile
  • upside potential of roughly 20% toward analyst median target
  • long‑term regulated revenue streams in water, waste and energy

Key Metrics & Analysis

Financial Health

Revenue Growth-18.20%
Profit Margin3.83%
P/E Ratio11.8
ROE11.61%
ROA3.25%
Debt/Equity120.51
P/B Ratio1.3
Op. Cash Flow€1.3B
Free Cash Flow€64.9M
Industry P/E20.7

Technical Analysis

TrendBearish
RSI42.6
Support€3.72
Resistance€3.95
MA 20€3.82
MA 50€3.94
MA 200€3.99
MACDBullish
VolumeIncreasing
Fear & Greed Index92.77

Valuation

Target Price€4.52
Upside/Downside19.58%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.22
Volatility16.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.